Watch this live webinar on Blazing a Trail for Down Syndrome Inclusion in Clinical Trials: What’s Next?
December 13, 2018
Click Here to register
Now that Down syndrome research is ready for clinical trials, LuMind RDS is tackling the challenges that prevent individuals with Down syndrome from being included in trials.
In our upcoming webinar on December 13, James Hendrix, LuMind RDS Chief Scientific Officer, reviews the opportunities and challenges of the clinical trial process, from Phase 1 to FDA approval, and why DS-CTN is a game changer.
This webinar will provide families with a clear understanding of what to expect as we enter this exciting next step towards safe and effective interventions to improve health and independence for all individuals with Down syndrome.